Market Overview

Looking For Amazon-Proof Stocks? Try Henry Schein

Share:
Looking For Amazon-Proof Stocks? Try Henry Schein
Related HSIC
Earnings Scheduled For November 6, 2018
Henry Schein's Q3 Earnings Outlook

Amazon.com, Inc. (NASDAQ: AMZN) is reportedly looking to enter the medical supply industry, but analysts at Piper Jaffray aren't concerned this will disrupt Henry Schein, Inc. (NASDAQ: HSIC)'s business.

Analyst Sarah James upgraded Henry Schein's stock from Neutral to Overweight with a price target boosted from $190 to $193.

Despite popular belief, Amazon's business model doesn't imply it can enter every single category it chooses, the analyst suggested. In fact, the company tends to avoid high touch industries that require a localized sales team and showrooms. Amazon would also require customization business practices and ongoing support if it were to compete against Henry Schein's value added services, which would be vital to growing share and retention in distribution.

Henry Schein is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners.

"We believe there is a very low likelihood Amazon could cut into HSIC's growth opportunity, view the product overlap potential as small, and view the recent stock pressure on this thesis as overdone," James wrote.

Amazon's potential disruption to Henry Schein played a part in the stock's decline since the second quarter, the analyst said. Yet at the same time the company is poised for dental consumable growth, winning market share with further upside coming from the recent Sirona deal.

As such, the stock's valuation appears attractive with a PEG (2010 PE, LT Growth) ratio of 2.1x and a 0.6 to 0.8x delta relative to other Overweight stocks under the analyst's coverage.

The recent pressure to Henry Schein's stock has created an "attractive" entry point for investors for a "high quality, low earnings risk" company.

See Also:

Patterson's Growth, Market Share At Risk In The Years Ahead

Benzinga's Top Upgrades, Downgrades For September 15, 2017

Latest Ratings for HSIC

DateFirmActionFromTo
Oct 2018Edward JonesDowngradesHoldSell
Oct 2018Morgan StanleyMaintainsUnderweightUnderweight
Aug 2018BairdMaintainsOutperformOutperform

View More Analyst Ratings for HSIC
View the Latest Analyst Ratings

Posted-In: Amazon Dental Dental StocksAnalyst Color Upgrades Price Target Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (AMZN + HSIC)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ALRMImperial CapitalUpgrades58.0
ANDXSunTrust Robinson HumphreyDowngrades41.0
CMANomuraDowngrades86.0
CSLLongbow ResearchUpgrades122.0
HBANNomuraDowngrades15.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Encana Could Be On The Verge Of A 5-Year Long Growth Spurt

Autoliv Shares Are Overvalued, But Don't Sell Just Yet